These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cardiac contractility modulation: mechanisms of action in heart failure with reduced ejection fraction and beyond. Tschöpe C; Kherad B; Klein O; Lipp A; Blaschke F; Gutterman D; Burkhoff D; Hamdani N; Spillmann F; Van Linthout S Eur J Heart Fail; 2019 Jan; 21(1):14-22. PubMed ID: 30485591 [TBL] [Abstract][Full Text] [Related]
3. Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure. Imai M; Rastogi S; Gupta RC; Mishra S; Sharov VG; Stanley WC; Mika Y; Rousso B; Burkhoff D; Ben-Haim S; Sabbah HN J Am Coll Cardiol; 2007 May; 49(21):2120-8. PubMed ID: 17531662 [TBL] [Abstract][Full Text] [Related]
4. Cardiac contractility modulation: a novel approach for the treatment of heart failure. Abi-Samra F; Gutterman D Heart Fail Rev; 2016 Nov; 21(6):645-660. PubMed ID: 27394714 [TBL] [Abstract][Full Text] [Related]
5. Impact of cardiac contractility modulation on left ventricular global and regional function and remodeling. Yu CM; Chan JY; Zhang Q; Yip GW; Lam YY; Chan A; Burkhoff D; Lee PW; Fung JW JACC Cardiovasc Imaging; 2009 Dec; 2(12):1341-9. PubMed ID: 20083066 [TBL] [Abstract][Full Text] [Related]
6. Improvement of long-term survival by cardiac contractility modulation in heart failure patients: A case-control study. Liu M; Fang F; Luo XX; Shlomo BH; Burkhoff D; Chan JY; Chan CP; Cheung L; Rousso B; Gutterman D; Yu CM Int J Cardiol; 2016 Mar; 206():122-6. PubMed ID: 26788686 [TBL] [Abstract][Full Text] [Related]
7. Role of Cardiac Contractility Modulation in Heart Failure With a Higher Ejection Fraction. Talha KM; Anker SD; Burkhoff D; Filippatos G; Lam CSP; Stone GW; Wazni O; Butler J J Card Fail; 2022 Dec; 28(12):1717-1726. PubMed ID: 36122819 [TBL] [Abstract][Full Text] [Related]
8. A randomized comparison of 5 versus 12 hours per day of cardiac contractility modulation treatment for heart failure patients: A preliminary report. Kloppe A; Mijic D; Schiedat F; Bogossian H; Mügge A; Rousso B; Lemke B Cardiol J; 2016; 23(1):114-9. PubMed ID: 26503077 [TBL] [Abstract][Full Text] [Related]
9. [The effectiveness of cardiac contractility modulation in patients with chronic heart failure and atrial fibrillation: results of the 12-month follow-up]. Safiullina AA; Uskach TM; Sapelnikov OV; Grishin IR; Cherkashin DI; Amanatova VA; Akchurin RS; Tereshchenko SN Ter Arkh; 2022 Oct; 94(9):1078-1084. PubMed ID: 36286759 [TBL] [Abstract][Full Text] [Related]
10. Cardiac contractility modulation in patients with heart failure - A review of the literature. Bazoukis G; Saplaouras A; Efthymiou P; Yiannikourides A; Liu T; Letsas KP; Efremidis M; Lampropoulos K; Xydonas S; Tse G; Armoundas AA Heart Fail Rev; 2024 May; 29(3):689-705. PubMed ID: 38393423 [TBL] [Abstract][Full Text] [Related]
11. Cardiac contractility modulation for the treatment of heart failure with reduced ejection fraction. Patel PA; Nadarajah R; Ali N; Gierula J; Witte KK Heart Fail Rev; 2021 Mar; 26(2):217-226. PubMed ID: 32852661 [TBL] [Abstract][Full Text] [Related]
12. Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation. Röger S; Schneider R; Rudic B; Liebe V; Stach K; Schimpf R; Borggrefe M; Kuschyk J Europace; 2014 Aug; 16(8):1205-9. PubMed ID: 24706089 [TBL] [Abstract][Full Text] [Related]
13. Comparison of left ventricular reverse remodeling induced by cardiac contractility modulation and cardiac resynchronization therapy in heart failure patients with different QRS durations. Zhang Q; Chan YS; Liang YJ; Fang F; Lam YY; Chan CP; Lee AP; Chan KC; Wu EB; Yu CM Int J Cardiol; 2013 Aug; 167(3):889-93. PubMed ID: 22330007 [TBL] [Abstract][Full Text] [Related]
14. Should HFrEF patients with NYHA class II expect benefit from CCM therapy? Results from the MAINTAINED observational study. Fastner C; Yuecel G; Hetjens S; Rudic B; Schmiel G; Toepel M; Liebe V; Kruska M; Borggrefe M; Burkhoff D; Akin I; Duerschmied D; Kuschyk J Clin Res Cardiol; 2022 Nov; 111(11):1286-1294. PubMed ID: 36056955 [TBL] [Abstract][Full Text] [Related]
15. Cardiac Contractility Modulation and Baroreflex Activation Therapy in Heart Failure Patients. Mann JA; Abraham WT Curr Heart Fail Rep; 2019 Feb; 16(1):38-46. PubMed ID: 30762177 [TBL] [Abstract][Full Text] [Related]
16. Clinical effects of long-term cardiac contractility modulation (CCM) in subjects with heart failure caused by left ventricular systolic dysfunction. Müller D; Remppis A; Schauerte P; Schmidt-Schweda S; Burkhoff D; Rousso B; Gutterman D; Senges J; Hindricks G; Kuck KH Clin Res Cardiol; 2017 Nov; 106(11):893-904. PubMed ID: 28685207 [TBL] [Abstract][Full Text] [Related]
17. Cardiac contractility modulation with the impulse dynamics signal: studies in dogs with chronic heart failure. Sabbah HN; Haddad W; Mika Y; Nass O; Aviv R; Sharov VG; Maltsev V; Felzen B; Undrovinas AI; Goldstein S; Darvish N; Ben-Haim SA Heart Fail Rev; 2001 Jan; 6(1):45-53. PubMed ID: 11248767 [TBL] [Abstract][Full Text] [Related]
18. A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with moderately reduced left ventricular ejection fraction and a narrow QRS duration: study rationale and design. Abraham WT; Lindenfeld J; Reddy VY; Hasenfuss G; Kuck KH; Boscardin J; Gibbons R; Burkhoff D; J Card Fail; 2015 Jan; 21(1):16-23. PubMed ID: 25285748 [TBL] [Abstract][Full Text] [Related]